Literature DB >> 24673111

Temporal definition of haematopoietic stem cell niches in a large animal model of in utero stem cell transplantation.

Christine Jeanblanc1, Angelina Daisy Goodrich, Evan Colletti, Saloomeh Mokhtari, Christopher D Porada, Esmail D Zanjani, Graça Almeida-Porada.   

Abstract

The fetal sheep model has served as a biologically relevant and translational model to study in utero haematopoietic stem cell transplantation (IUHSCT), yet little is known about the ontogeny of the bone marrow (BM) niches in this model. Because the BMmicroenvironment plays a critical role in the outcome of haematopoietic engraftment, we have established the correlation between the fetal-sheep and fetal-human BM niche ontogeny, so that studies addressing the role of niche development at the time of IUHSCT could be accurately performed. Immunofluorescence confocal microscopic analysis of sheep fetal bone from gestational days (gd) 25-68 showed that the BM microenvironment commences development with formation of the vascular niche between 25 and 36 gd in sheep; correlating with the events at 10-11 gestational weeks (gw) in humans. Subsequently, between 45 and 51 gd in sheep (c. 14 gw in humans), the osteoblastic/endosteal niche started developing, the presence of CD34(+)  CD45(+) cells were promptly detected, and their number increased with gestational age. IUHSCT, performed in sheep at 45 and 65 gd, showed significant haematopoietic engraftment only at the later time point, indicating that a fully functional BM microenvironment improved engraftment. These studies show that sheep niche ontogeny closely parallels human, validating this model for investigating niche influence/manipulation in IUHSCT engraftment.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  haematopoietic niche; in utero; osteoblast; transplantation; vascular

Mesh:

Substances:

Year:  2014        PMID: 24673111      PMCID: PMC4079736          DOI: 10.1111/bjh.12870

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  43 in total

Review 1.  In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers.

Authors:  A W Flake; E D Zanjani
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

Review 2.  The human/sheep xenograft model: a large animal model of human hematopoiesis.

Authors:  E D Zanjani; G Almeida-Porada; A W Flake
Journal:  Int J Hematol       Date:  1996-04       Impact factor: 2.490

Review 3.  In utero stem cell transplantation.

Authors:  Alan W Flake
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2004-12       Impact factor: 5.237

4.  Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies.

Authors:  M Westgren; O Ringden; S Eik-Nes; S Ek; M Anvret; A M Brubakk; T H Bui; A Giambona; T Kiserud; A Kjaeldgaard; A Maggio; L Markling; A Seiger; F Orlandi
Journal:  Transplantation       Date:  1996-04-27       Impact factor: 4.939

5.  Engraftment kinetics of human cord blood and murine fetal liver stem cells following in utero transplantation into immunodeficient mice.

Authors:  Andreina Schoeberlein; Stephan Schatt; Carolyn Troeger; Daniel Surbek; Wolfgang Holzgreve; Sinuhe Hahn
Journal:  Stem Cells Dev       Date:  2004-12       Impact factor: 3.272

6.  Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow.

Authors:  A W Flake; M G Roncarolo; J M Puck; G Almeida-Porada; M I Evans; M P Johnson; E M Abella; D D Harrison; E D Zanjani
Journal:  N Engl J Med       Date:  1996-12-12       Impact factor: 91.245

7.  The fetus as an optimal donor and recipient of hemopoietic stem cells.

Authors:  E D Zanjani; J L Ascensao; A W Flake; M R Harrison; M Tavassoli
Journal:  Bone Marrow Transplant       Date:  1992       Impact factor: 5.483

8.  Early ontogeny of the human marrow from long bones: an immunohistochemical study of hematopoiesis and its microenvironment.

Authors:  P Charbord; M Tavian; L Humeau; B Péault
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

9.  Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep.

Authors:  E D Zanjani; A W Flake; H Rice; M Hedrick; M Tavassoli
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Fetal liver cell transplantation for the creation of lymphohematopoietic chimerism in fetal baboons.

Authors:  L E Shields; E M Bryant; T R Easterling; R G Andrews
Journal:  Am J Obstet Gynecol       Date:  1995-10       Impact factor: 8.661

View more
  11 in total

1.  Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model.

Authors:  A Daisy Goodrich; Nicole M Varain; Christine M Jeanblanc; Donna M Colon; Jaehyup Kim; Esmail D Zanjani; Peiman Hematti
Journal:  Cytotherapy       Date:  2014-09       Impact factor: 5.414

Review 2.  Hemophilia A: an ideal disease to correct in utero.

Authors:  Christopher D Porada; Christopher Rodman; Glicerio Ignacio; Anthony Atala; Graça Almeida-Porada
Journal:  Front Pharmacol       Date:  2014-12-11       Impact factor: 5.810

3.  Boosting Hematopoietic Engraftment after in Utero Transplantation through Vascular Niche Manipulation.

Authors:  Saloomeh Mokhtari; Evan J Colletti; Anthony Atala; Esmail D Zanjani; Christopher D Porada; Graça Almeida-Porada
Journal:  Stem Cell Reports       Date:  2016-06-14       Impact factor: 7.765

Review 4.  In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases.

Authors:  Neeladri Chowdhury; Atsushi Asakura
Journal:  Stem Cells Int       Date:  2017-05-15       Impact factor: 5.443

Review 5.  Large Animal Models in Regenerative Medicine and Tissue Engineering: To Do or Not to Do.

Authors:  Iris Ribitsch; Pedro M Baptista; Anna Lange-Consiglio; Luca Melotti; Marco Patruno; Florien Jenner; Eva Schnabl-Feichter; Luke C Dutton; David J Connolly; Frank G van Steenbeek; Jayesh Dudhia; Louis C Penning
Journal:  Front Bioeng Biotechnol       Date:  2020-08-13

Review 6.  In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System.

Authors:  Alba Saenz de Villaverde Cortabarria; Laura Makhoul; John Strouboulis; Giovanna Lombardi; Eugene Oteng-Ntim; Panicos Shangaris
Journal:  Front Cell Dev Biol       Date:  2021-01-22

7.  Molecular Mechanisms of Fetal Tendon Regeneration Versus Adult Fibrous Repair.

Authors:  Iris Ribitsch; Andrea Bileck; Alexander D Aldoshin; Maciej M Kańduła; Rupert L Mayer; Monika Egerbacher; Simone Gabner; Ulrike Auer; Sinan Gültekin; Johann Huber; David P Kreil; Christopher Gerner; Florien Jenner
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

8.  Preterm Cord Blood Contains a Higher Proportion of Immature Hematopoietic Progenitors Compared to Term Samples.

Authors:  Marina Podestà; Matteo Bruschettini; Claudia Cossu; Federica Sabatini; Monica Dagnino; Olga Romantsik; Grazia Maria Spaggiari; Luca Antonio Ramenghi; Francesco Frassoni
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

Review 9.  In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application.

Authors:  Graça Almeida-Porada; Anthony Atala; Christopher D Porada
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-30       Impact factor: 6.698

10.  Fetal articular cartilage regeneration versus adult fibrocartilaginous repair: secretome proteomics unravels molecular mechanisms in an ovine model.

Authors:  Iris Ribitsch; Rupert L Mayer; Monika Egerbacher; Simone Gabner; Maciej M Kańduła; Julie Rosser; Eva Haltmayer; Ulrike Auer; Sinan Gültekin; Johann Huber; Andrea Bileck; David P Kreil; Christopher Gerner; Florien Jenner
Journal:  Dis Model Mech       Date:  2018-07-06       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.